Catalyst Pharmaceuticals (CPRX) Change in Inventory (2019 - 2026)
Catalyst Pharmaceuticals posted quarterly Change in Inventory of -$2.2 million for Q1 2026, down 1043.46% year-on-year from $237000.0 in Q1 2025, and down 124.25% on a QoQ basis from $9.2 million in Q4 2025.
Catalyst Pharmaceuticals (CPRX) has 8 years of Change in Inventory data on file, last reported at -$2.2 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Inventory fell 1043.46% year-over-year to -$2.2 million; the trailing twelve-month figure through Mar 2026 stood at $15.6 million (up 9023.43% YoY), and the FY2025 full-year result was $18.1 million, up 364.18% from the prior year.
- Change in Inventory for Q1 2026 stood at -$2.2 million, down from $9.2 million in the prior quarter.
- Across five years, Change in Inventory topped out at $9.2 million in Q4 2025 and bottomed at -$2.2 million in Q1 2026.
- The 5-year median for Change in Inventory is -$43000.0 (2022), against an average of $1.4 million.
- Peak annual rise in Change in Inventory reached 2121.1% in 2023, while the deepest fall reached 1241.86% in 2023.
- A 5-year view of Change in Inventory shows it stood at -$327000.0 in 2022, then soared by 2121.1% to $6.6 million in 2023, then plunged by 107.2% to -$476000.0 in 2024, then jumped by 2036.97% to $9.2 million in 2025, then tumbled by 124.25% to -$2.2 million in 2026.
- The last three Change in Inventory figures came in at -$2.2 million (Q1 2026), $9.2 million (Q4 2025), and $9.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 665.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 97.70 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -26.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.32 Mn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn | -2.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.24 Mn |
| Mar 31, 2026 | -2.24 Mn |
| Dec 31, 2025 | 9.22 Mn |
| Dec 31, 2025 | 9.22 Mn |
| Sep 30, 2025 | 9.09 Mn |
| Sep 30, 2025 | 9.09 Mn |
| Jun 30, 2025 | -455,000.00 |
| Jun 30, 2025 | -455,000.00 |
| Mar 31, 2025 | 237,000.00 |
| Mar 31, 2025 | 237,000.00 |
| Dec 31, 2024 | -476,000.00 |
| Dec 31, 2024 | -476,000.00 |
| Sep 30, 2024 | 2.00 Mn |
| Sep 30, 2024 | 2.00 Mn |
| Jun 30, 2024 | -1.94 Mn |
| Jun 30, 2024 | -1.94 Mn |
| Mar 31, 2024 | 4.31 Mn |
| Mar 31, 2024 | 4.31 Mn |
| Dec 31, 2023 | 6.61 Mn |
| Dec 31, 2023 | 6.61 Mn |
| Sep 30, 2023 | -1.72 Mn |
| Sep 30, 2023 | -1.72 Mn |
| Jun 30, 2023 | 423,000.00 |
| Jun 30, 2023 | 423,000.00 |
| Mar 31, 2023 | -577,000.00 |
| Mar 31, 2023 | -577,000.00 |
| Dec 31, 2022 | -327,000.00 |
| Dec 31, 2022 | -327,000.00 |
| Sep 30, 2022 | -718,000.00 |
| Sep 30, 2022 | -718,000.00 |
| Jun 30, 2022 | 23,000.00 |
| Jun 30, 2022 | 23,000.00 |
| Mar 31, 2022 | -43,000.00 |
| Mar 31, 2022 | -43,000.00 |
| Dec 31, 2021 | 920,000.00 |
| Dec 31, 2021 | 920,000.00 |
| Sep 30, 2021 | -147,000.00 |
| Sep 30, 2021 | -147,000.00 |
| Jun 30, 2021 | 2.71 Mn |
| Jun 30, 2021 | 2.71 Mn |
| Mar 31, 2021 | -261,000.00 |
| Mar 31, 2021 | -261,000.00 |
| Dec 31, 2020 | -97,000.00 |
| Dec 31, 2020 | -97,000.00 |
| Sep 30, 2020 | 2.92 Mn |
| Sep 30, 2020 | 2.92 Mn |
| Jun 30, 2020 | -383,000.00 |
| Jun 30, 2020 | -383,000.00 |
| Mar 31, 2020 | 254,000.00 |
| Mar 31, 2020 | 254,000.00 |
| Dec 31, 2019 | 1.36 Mn |
| Dec 31, 2019 | 1.36 Mn |
| Sep 30, 2019 | 329,922.00 |
| Sep 30, 2019 | 329,922.00 |
| Jun 30, 2019 | 173,292.00 |
| Jun 30, 2019 | 173,292.00 |
| Mar 31, 2019 | 40,575.00 |
| Mar 31, 2019 | 40,575.00 |